Anesthesia & Intensive Care, Department of Clinical Sciences Lund, Lund University, Helsingborg Hospital, Helsingborg, Sweden.
Anesthesia & Intensive Care, Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, Sweden.
Resuscitation. 2023 Jul;188:109831. doi: 10.1016/j.resuscitation.2023.109831. Epub 2023 May 11.
This study investigated the association of two levels of targeted temperature management (TTM) after out-of-hospital cardiac arrest (OHCA) with administered doses of sedative and analgesic drugs, serum concentrations, and the effect on time to awakening.
This substudy of the TTM2-trial was conducted at three centers in Sweden, with patients randomized to either hypothermia or normothermia. Deep sedation was mandatory during the 40-hour intervention. Blood samples were collected at the end of TTM and end of protocolized fever prevention (72 hours). Samples were analysed for concentrations of propofol, midazolam, clonidine, dexmedetomidine, morphine, oxycodone, ketamine and esketamine. Cumulative doses of administered sedative and analgesic drugs were recorded.
Seventy-one patients were alive at 40 hours and had received the TTM-intervention according to protocol. 33 patients were treated at hypothermia and 38 at normothermia. There were no differences between cumulative doses and concentration and of sedatives/analgesics between the intervention groups at any timepoint. Time until awakening was 53 hours in the hypothermia group compared to 46 hours in the normothermia group (p = 0.09).
This study of OHCA patients treated at normothermia versus hypothermia found no significant differences in dosing or concentration of sedatives or analgesic drugs in blood samples drawn at the end of the TTM intervention, or at end of protocolized fever prevention, nor the time to awakening.
本研究调查了院外心脏骤停(OHCA)后两种目标温度管理(TTM)水平与镇静和镇痛药物的给药剂量、血清浓度以及对觉醒时间的影响。
本研究是 TTM2 试验的一个子研究,在瑞典的三个中心进行,患者随机分为低温组或常温组。在 40 小时的干预过程中必须进行深度镇静。在 TTM 结束时和方案规定的发热预防结束时(72 小时)采集血样。分析样本中丙泊酚、咪达唑仑、可乐定、右美托咪定、吗啡、羟考酮、氯胺酮和 Esketamine 的浓度。记录给予镇静和镇痛药物的累积剂量。
71 名患者在 40 小时时存活并按方案接受了 TTM 干预。33 例患者接受低温治疗,38 例接受常温治疗。在任何时间点,干预组之间的累积剂量和镇静/镇痛药物的浓度均无差异。低温组的觉醒时间为 53 小时,常温组为 46 小时(p=0.09)。
本研究对常温治疗与低温治疗的 OHCA 患者进行了研究,发现在 TTM 干预结束时和方案规定的发热预防结束时抽取的血液样本中,镇静和镇痛药物的剂量或浓度,以及觉醒时间均无显著差异。